Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung Cancer

Background and Purpose. The mevalonate pathway is one of the major metabolic pathways that use acetyl-CoA to produce sterols and isoprenoids. These compounds can be effective in the growth and development of tumors. One of the enzymes involved in the mevalonate pathway is FDFT1. Different variants o...

Full description

Saved in:
Bibliographic Details
Main Authors: Mehdi Dehghani, Zahra Samani, Hassan Abidi, Leila Manzouri, Reza Mahmoudi, Saeed Hosseini Teshnizi, Mohsen Nikseresht
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2018/4863757
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849398803288817664
author Mehdi Dehghani
Zahra Samani
Hassan Abidi
Leila Manzouri
Reza Mahmoudi
Saeed Hosseini Teshnizi
Mohsen Nikseresht
author_facet Mehdi Dehghani
Zahra Samani
Hassan Abidi
Leila Manzouri
Reza Mahmoudi
Saeed Hosseini Teshnizi
Mohsen Nikseresht
author_sort Mehdi Dehghani
collection DOAJ
description Background and Purpose. The mevalonate pathway is one of the major metabolic pathways that use acetyl-CoA to produce sterols and isoprenoids. These compounds can be effective in the growth and development of tumors. One of the enzymes involved in the mevalonate pathway is FDFT1. Different variants of this gene are involved in the risk of suffering various diseases. The present study examined the relationship between FDFT1 rs2645429 polymorphism and the risk of nonsmall cell lung cancer (NSCLC) in a population from southern Iran. Method. The genotypes of rs2645429 polymorphism of FDFT1 gene were examined in 95 samples: 34 patients with NSCLC and 61 healthy individuals by RFLP method. Results. The results of this study indicated that C allele of this polymorphism was effectively associated with the risk of NSCLC in the Iranian population (p value = 0.023; OR = 2.71; 95% CI = 1.12–6.59) and CC genotype has significant relation with susceptibility to NSCLC (p value = 0.029; OR = 3.02; 95% CI = 1.09–8.39). This polymorphism is located in the promoter region FDFT1 gene, and CC genotype may increase the activity of this promoter. This study also found a significant relationship between C allele and metastatic status. C allele was more common in NSCLC patients. (p=0.04). Conclusion. C allele of FDFT1 rs2645429 polymorphism gene can be a risk factor for NSCLC, whereas T allele probably has a low protective role.
format Article
id doaj-art-9f00d57d60e24000913875afe976a2fa
institution Kabale University
issn 2314-436X
2314-4378
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-9f00d57d60e24000913875afe976a2fa2025-08-20T03:38:30ZengWileyInternational Journal of Genomics2314-436X2314-43782018-01-01201810.1155/2018/48637574863757Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung CancerMehdi Dehghani0Zahra Samani1Hassan Abidi2Leila Manzouri3Reza Mahmoudi4Saeed Hosseini Teshnizi5Mohsen Nikseresht6Hematology and Medical Oncology Department, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, IranCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, IranCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, IranSocial Determinant of Health Research Center, Yasuj University of Medical Sciences, Yasuj, IranCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, IranBiostatistican, Molecular Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, IranCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, IranBackground and Purpose. The mevalonate pathway is one of the major metabolic pathways that use acetyl-CoA to produce sterols and isoprenoids. These compounds can be effective in the growth and development of tumors. One of the enzymes involved in the mevalonate pathway is FDFT1. Different variants of this gene are involved in the risk of suffering various diseases. The present study examined the relationship between FDFT1 rs2645429 polymorphism and the risk of nonsmall cell lung cancer (NSCLC) in a population from southern Iran. Method. The genotypes of rs2645429 polymorphism of FDFT1 gene were examined in 95 samples: 34 patients with NSCLC and 61 healthy individuals by RFLP method. Results. The results of this study indicated that C allele of this polymorphism was effectively associated with the risk of NSCLC in the Iranian population (p value = 0.023; OR = 2.71; 95% CI = 1.12–6.59) and CC genotype has significant relation with susceptibility to NSCLC (p value = 0.029; OR = 3.02; 95% CI = 1.09–8.39). This polymorphism is located in the promoter region FDFT1 gene, and CC genotype may increase the activity of this promoter. This study also found a significant relationship between C allele and metastatic status. C allele was more common in NSCLC patients. (p=0.04). Conclusion. C allele of FDFT1 rs2645429 polymorphism gene can be a risk factor for NSCLC, whereas T allele probably has a low protective role.http://dx.doi.org/10.1155/2018/4863757
spellingShingle Mehdi Dehghani
Zahra Samani
Hassan Abidi
Leila Manzouri
Reza Mahmoudi
Saeed Hosseini Teshnizi
Mohsen Nikseresht
Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung Cancer
International Journal of Genomics
title Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung Cancer
title_full Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung Cancer
title_fullStr Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung Cancer
title_full_unstemmed Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung Cancer
title_short Relationship of SNP rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1 Gene Promoter with Susceptibility to Lung Cancer
title_sort relationship of snp rs2645429 in farnesyl diphosphate farnesyltransferase 1 gene promoter with susceptibility to lung cancer
url http://dx.doi.org/10.1155/2018/4863757
work_keys_str_mv AT mehdidehghani relationshipofsnprs2645429infarnesyldiphosphatefarnesyltransferase1genepromoterwithsusceptibilitytolungcancer
AT zahrasamani relationshipofsnprs2645429infarnesyldiphosphatefarnesyltransferase1genepromoterwithsusceptibilitytolungcancer
AT hassanabidi relationshipofsnprs2645429infarnesyldiphosphatefarnesyltransferase1genepromoterwithsusceptibilitytolungcancer
AT leilamanzouri relationshipofsnprs2645429infarnesyldiphosphatefarnesyltransferase1genepromoterwithsusceptibilitytolungcancer
AT rezamahmoudi relationshipofsnprs2645429infarnesyldiphosphatefarnesyltransferase1genepromoterwithsusceptibilitytolungcancer
AT saeedhosseiniteshnizi relationshipofsnprs2645429infarnesyldiphosphatefarnesyltransferase1genepromoterwithsusceptibilitytolungcancer
AT mohsennikseresht relationshipofsnprs2645429infarnesyldiphosphatefarnesyltransferase1genepromoterwithsusceptibilitytolungcancer